Some considerations on the role of benzodiazepines in the treatment of depression.
- 1 February 1981
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 11 (S1), 23S-29S
- https://doi.org/10.1111/j.1365-2125.1981.tb01835.x
Abstract
1 Benzodiazepines are regarded as pure anxiolytics, and their value in the treatment of depression is controversial. Nevertheless, symptoms of anxiety and depression coexist in patients with endogenous or neurotic depression, and clinical trials indicate that depressed patients respond better to a benzodiazepine‐tricyclic antidepressant combination than to either drug alone. 2 Benzodiazepines may extend tricyclic antidepression efficacy by rapidly relieving anxiety and insomnia. Factor analysis of scores obtained using the Hamilton Depression and Self‐Administered Depression Rating Scales confirm the clinical findings by revealing that a close correlation exists among anxiety, insomnia and endogenous depression. The factor analysis data seem to support the wide use of benzodiazepine‐tricyclic combinations to treat depressed patients.Keywords
This publication has 36 references indexed in Scilit:
- A double‐blind comparison of flupenthixol, nortriptyline and diazepam in neurotic depressionActa Psychiatrica Scandinavica, 1979
- Benzodiazepines in Depressive DisordersSouthern Medical Journal, 1978
- Anxiety, Depression and Psychotropic DrugsDrugs, 1971
- A Comparison of Two Drug Treatments in Depressive IllnessThe British Journal of Psychiatry, 1969
- Activity Study of Doxepin: A New AntidepressantPsychosomatics, 1968
- A Comparative Trial of Ro 4-6270 and Amitriptyline in Depressive IllnessThe British Journal of Psychiatry, 1967
- Treatment of childhood depression with antidepressant drugs.BMJ, 1967
- Reflections on the Specificity of Action of Anti-DepressantsPsychosomatics, 1965
- Problems of Differential Diagnosis and Choice of Therapy in Depressive StatesPsychosomatics, 1965
- Amitriptyline in depressive statesJournal of Mental Science, 1962